Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $82,119,756    

Indirect Value

  $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp
 $32,589,847 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $312,474 Neurogene
 $16,634 Incyte Corp
 $32,589,847 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $312,474 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
INCY Incyte Corp Director   –       •       •   2009-03-05 4 B $2.16 $138 I/I 64 139,615 2.17 -
INCY Incyte Corp Director   –       •       •   2008-01-22 4 B $10.62 $690 I/I 65 3,046,922 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-08 4 B $19.67 $1,318 I/I 67 193,954 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-01-09 4 S $13.00 $884 I/I (68) 28,734 0 -
SGEN Seagen Inc Director   –       •       •   2008-02-07 4 B $9.00 $630 I/I 70 476,243 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-05-10 4 B $2.65 $188 I/I 71 1,246 1.42 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-04-17 4 B $13.28 $1,009 I/I 76 136,889 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-20 4 B $17.88 $1,439 I/I 80 194,151 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-10 4 B $4.03 $335 I/I 83 91,863 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2009-05-08 4 B $5.92 $492 I/I 83 105,326 1.42 -
INCY Incyte Corp Director   –       •       •   2008-01-11 4 B $10.94 $919 I/I 84 281,949 2.17 -
SGEN Seagen Inc Director   –       •       •   2005-03-28 4 B $4.90 $417 I/I 85 15,828 2.17 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-11 4 S $12.25 $1,041 I/I (85) 30,405 0 -
INCY Incyte Corp Director   –       •       •   2008-12-22 4/A B $3.25 $276 I/I 85 7,027,385 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-25 4 B $6.00 $546 I/I 91 191,820 1.42 -
INCY Incyte Corp Director   –       •       •   2008-01-14 4 B $10.99 $1,033 I/I 94 282,043 2.17 -
SGEN Seagen Inc Director   –       •       •   2008-02-07 4 B $9.00 $873 I/I 97 363,765 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2008-10-21 4 A $2.74 $269 I/I 98 75,075 0 -
INCY Incyte Corp Director   –       •       •   2009-03-03 4 B $2.14 $210 I/I 98 139,551 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-11 4 B $7.47 $770 I/I 103 191,021 1.42 -
SGEN Seagen Inc Director   –       •       •   2008-02-11 4 B $9.06 $933 I/I 103 476,588 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-19 4 B $6.75 $696 I/I 103 191,493 1.42 -
SGEN Seagen Inc Director   –       •       •   2008-03-13 4 B $7.93 $816 I/I 103 476,722 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-20 4 B $6.50 $676 I/I 104 191,597 1.42 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2005-04-12 4 B $3.57 $375 I/I 105 105 1.42 -

  1397  Records found
  1   2   3   4   5   6  7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 6 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed